Content
RenovoRX's Latest Innovative Technology Creates New Hope For Chemotherapy Patients
Article By:
Shareholders Unite
Read
Tuesday, February 28, 2023 11:15 PM EDT
RenovoRx takes existing chemotherapies and makes them more effective and less invasive, by being able to concentrate most of the chemotherapy agent on the tumor itself.
In this article: RNXT
SurgePays Inc: A Strong Investment Opportunity In 2023
Video By:
TalkMarkets TV
Watch
Monday, January 23, 2023 12:00 PM EDT
Get an inside look at why SurgePays Inc. is a strong investment opportunity for 2023 and why smallcap investors should consider adding SURG to their portfolio.
In this video: SURG
BriaCell Therapeutics' Mission: Destroy Breast Cancer
Article By:
Lorimer Wilson
Read
Wednesday, January 18, 2023 9:59 AM EDT
BriaCell would make a great buy and hold investment. If, and when, it brings a product directly to market, or is acquired by a major pharmaceutical company, its stock price should go up dramatically.
BriaCell Announces Positive End Of Phase II Meeting With The FDA For Bria-IMT(TM) Combination In Advanced Metastatic Breast Cancer
Article By:
TalkMarkets Newswire
Read
Wednesday, January 18, 2023 8:56 AM EDT
Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach.
SOBRSafe: A Disruptive Stock Worth The Risk
Article By:
Kate Hayden
Read
Wednesday, December 21, 2022 10:36 AM EDT
If something is cheap enough, and interesting enough, and has some concrete indications of holding higher prices - and you are clear-eyed about it - 'risk' is not intrinsically bad.
Protalix BioTherapeutics Well Placed To Advance In 2023
Article By:
Shareholders Unite
Read
Monday, December 12, 2022 12:47 PM EDT
We see a number of reasons to be positive about PLX shares in 2023 and investors should take note.
One-On-One With AMMO, Inc. Management
Article By:
Avisol Capital Partners
Read
Thursday, November 24, 2022 8:07 AM EDT
We sat down with AMMO, Inc. management, including CEO Fred Wagenhals, to discuss their company. We asked about the Manitowoc plant, the management, their revenue and business plan, and their plans to split the company into two.
SOBRSafe: A Very Favorable Risk/Reward Play
Article By:
Shareholders Unite
Read
Tuesday, November 22, 2022 6:17 PM EDT
With an impressive upside potential and profitability now in sight, we think the current share price provides an attractive opportunity, despite the expected volatility.
In this article: SOBR
A Paradigm Shift In Healthcare Produces A Big Market Opportunity
Article By:
Shareholders Unite
Read
Tuesday, November 15, 2022 9:37 AM EDT
DarioHeath is poised to be a $100M+ company running 60%+ gross margins, be profitable and cash generating.
One-On-One With BriaCell Therapeutics Corp. Management
Article By:
Kate Hayden
Read
Thursday, October 27, 2022 12:18 PM EDT
BriaCell's lead candidate is Bria-IMT, a whole-cell cancer immunotherapy, combined with Incyte’s retifanlimab, for advanced breast cancer. We asked BriaCell’s CEO, William Williams, about the rationale for the combination.
A Ground Floor Opportunity In Splash Beverage
Article By:
Shareholders Unite
Read
Tuesday, October 11, 2022 10:11 AM EDT
We think Splash Beverage offers an exciting investment opportunity on the basis of their rapidly expanding distribution network and the potential of many of their latest distribution deals.
UK Government’s Green Energy Policy Is A “National Disaster”
Article By:
Net Zero Watch
Read
Thursday, September 1, 2022 12:12 PM EDT
Britain’s struggling energy consumers are likely to end up paying a billion pounds extra for Hornsea’s electricity over the next 12 months.